Evidence map›Paper›PMID 42261073›Full record

ReviewFEBS open bio2026

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer.

Stanislava Martínková, Jan Trnka

Abstract readReview
In one paragraph

Review in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stanislava MartínkováLaboratory of Metabolism and Bioenergetics, Department of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0009-0009-2344-3676
Jan TrnkaLaboratory of Metabolism and Bioenergetics, Department of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-1786-7562

Funding

Grantová Agentura České Republiky 26-23614SMinisterstvo Zemědělství QL24010123
6 · The paper itself

Abstract

Tunnelling nanotubes (TNTs) are thin intercellular membrane structures, which enable direct cytoplasmic communication between distant cells. Since their discovery two decades ago, TNTs have been identified in numerous physiological and pathological contexts. This includes cancer, where they contribute to metabolic cooperation, stress adaptation and treatment resistance. Here we summarise the current understanding of the structural and molecular characteristics of TNTs and their cargoes, including nucleic acids, proteins, organelles, pathogens and drugs. We also discuss the cytoskeletal and motor protein machinery underlying TNT biogenesis and cargo transport. Particular attention is also given to mitochondrial transfer and its role in intercellular metabolic cooperation or parasitism, mRNA transfer and its functional effects in recipient cells, and ribosome transfer which suggests intercellular proteosynthetic cooperation. Overall, while we have learned much about TNTs since their identification a little over 20 years ago, there remain significant questions and discoveries still to be made.

Indexed as

cancercytoskeletonmitochondrial transfermRNA transferribosomal transfertunnelling nanotubes

Identifiers

PMID42261073
PMCPMC13399049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.